Skip to main content

Table 1 US FDA approved immune checkpoint blockers for cancer immunotherapy as of Oct 2018

From: Recent updates in cancer immunotherapy: a comprehensive review and perspective of the 2018 China Cancer Immunotherapy Workshop in Beijing